Home9LB • FRA
add
Legend Biotech Corp
Previous close
€30.00
Day range
€29.80 - €29.80
Year range
€26.40 - €55.50
Market cap
6.30B USD
Avg Volume
34.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 186.52M | 134.73% |
Operating expense | 83.13M | 33.25% |
Net income | 26.28M | 118.15% |
Net profit margin | 14.09 | 107.73% |
Earnings per share | 0.14 | 117.50% |
EBITDA | -72.06M | 39.09% |
Effective tax rate | 35.12% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.12B | -14.21% |
Total assets | 1.67B | -9.65% |
Total liabilities | 629.61M | 5.42% |
Total equity | 1.04B | — |
Shares outstanding | 183.65M | — |
Price to book | 5.29 | — |
Return on assets | -11.00% | — |
Return on capital | -13.13% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 26.28M | 118.15% |
Cash from operations | -82.08M | 14.18% |
Cash from investing | -87.84M | -121.56% |
Cash from financing | -333.00K | -136.00% |
Net change in cash | -172.53M | -154.90% |
Free cash flow | -49.56M | 62.28% |
About
Founded
2014
Headquarters
Website
Employees
2,600
